The U.S. and European Union Osteoporosis Drugs Market Is Driven by Increasing Prevalence of Osteoporosis

The U.S. and European Union osteoporosis drugs market is experiencing growth, and this development can be credited to the growing occurrence rate of osteoporosis illnesses, the rising elderly populace, the rising cases of overweightness, the increasing occurrence of lifestyle-related illnesses, and the rising healthcare expenditure in the U.S. and the EU.

In 2022, the U.S. osteoporosis drugs industry size was valued at USD 6,210.4 million, and the market is projected to surge to USD 9,105.2 million by 2030, growing at a CAGR of 4.90% during the projection period. This is mainly because of the existence of a huge count of market giants, improved healthcare infrastructure, huge expenditure by the government in the healthcare industry, and augmented awareness regarding the illness in the nation.

In 2022, the European Union osteoporosis drugs industry size was valued at USD 2,965.4 million, and this count is additionally projected to surge to USD 4,265.4 million by 2030, growing at a CAGR of 4.65% during the projection period. This is credited to the rising elderly populace, altering lifestyles, fast urbanization, and growing knowledge regarding osteoporosis care in the region.

On the basis of type, the bisphosphonates category dominated the market with the largest revenue share, and it is additionally projected to endure its supremacy in the future as well. This is mainly because bisphosphonates have confirmed effectiveness in reducing fracture danger at the spine, hip, and other non-vertebral emaciated sites, surge the existence rate, and reduce the substantial danger of morbidity.

Furthermore, the rising number of females in the post-menopausal stage and a rise in the occurrence of bone illnesses will further contribute to the requirement for these medications.

According to World Health Organisation data, due to the increased prevalence of diseases and a growing number of government initiatives both public and private, health expenditure is on the rise around the world. As a result, the health infrastructure improves, and access to care and diagnosis is becoming more accessible for different diseases.

On the basis of application, the primary osteoporosis category accounts for a larger income share and it will also witness quicker development during the projection period. This is mainly because the mainstream cases that happened are of the primary type, which impacts females after menopause as a result of an unexpected decrease in estrogen production; the loss of bone structure because of the lack of testosterone in males; and the rising elderly populace in the U.S. and the EU.

Osteoporosis results in decreased bone mass and significant loss of bone which increases fracture risk. It impacts individuals of both sexes and all races/ethnicities. For example, in the U.S. alone, there are about 2 million osteoporosis-linked fractures, and the price associated with osteoporosis each year is approximately USD 19 billion. 

Read More

Osteoporosis Can be Controlled with Osteoporosis Drugs

Medical science has evolved a great deal to say the least, and there are treatments and drugs for almost all the health conditions. Some conditions can be treated to the core and others can be prevented or slowed down. We will talk about the medications for osteoporosis in this blog.

The medications for osteoporosis help in improving bone density and preventing fractures. Some meds help build more bone, while others decrease the degeneration of bones.   

With age, bones become weak faster than the repairing capacity of the body. If a lot of bone density is lost, there is a chance that you might have developed osteoporosis.

Get the sample pages of this report: https://bit.ly/3FSyD5B

It is not possible to cure osteoporosis, but drugs can decrease the rate of degeneration or even stop it at the stage, where it is. Regular exercise, intake of calcium and vitamin D, can surely make a difference.

When the condition does not improve with exercise or intake of calcium, drugs might be prescribed. When we talk about osteoporosis drugs, there are numerous options available.

Which Drug Is Right?

The doctor will prescribe a drug on the basis of the severity of the condition of the patient. But that’s not the only thing to be taken into consideration. Here are some factors that will also be taken into account:

Sex- Some medicines are suitable for women, while others might be suitable for both the sexes.

Age- Age also plays a major role in deciding the prescription of drug for osteoporosis. Some are best for younger women who’ve already been through the period of menopause, others are suitable for older women.

Ease of Taking Medicine- The drugs are available in the form of pills to shots. Some have to be taken every day, and some only once a year. The right medication for you is the one that works best as per your condition.

Cost is a Crucial Factor- Shots or drugs taken through an IV calls for a visit to the doctor. This may cost more than pills that can be administered at home only.

Medical History- It is very important for a doctor to have a look at the medical history before suggesting a medication. If a patient is already suffering from kidney issues, breast cancer, or trouble with esophagus, some medicines can be more beneficial in that case than others.

What are Types of Osteoporosis Drugs

• Antiresorptive drugs help to slow down the rate that the bone is degenerated. They comprise denosumab, bisphosphonates, estrogens, calcitonin, and others. 

• Anabolic drugs come in handy for increasing bone formation. Some of the prime examples are teriparatide and romosozumab.

The drugs suggested, takes into account many things, such as whether they prevent or treat osteoporosis along with other medical conditions. Not all drugs are suitable for all people suffering from osteoporosis. For instance, a drug accepted to treating osteoporosis in women may not do the same in men. A specialist should be consulted to know that drug prescribed is perfectly suitable or not.

A lot of people in the world are suffering from osteoporosis and take drugs for the same, that is why the demand for the same is on the rise and will reach a value of USD 22,947 million by 2030.

Read More